Patterns of minimal residual disease after high dose therapy in myeloma - A comparison of allografting and autografting.

被引：0
|
作者：
Haynes, AP
Carter, GI
Owen, R
Davis, F
Byrne, J
Bybee, A
Samsom, D
Morgan, GJ
Russell, NH
机构：
[1] CITY HOSP NOTTINGHAM,DEPT HAEMATOL,NOTTINGHAM,ENGLAND
[2] LEEDS GEN INFIRM,LEEDS,W YORKSHIRE,ENGLAND
[3] HAMMERSMITH HOSP,LONDON,ENGLAND
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：995 / 995
页数：1
相关论文
共 50 条
  • [31] Minimal residual disease testing after stem cell transplantation for multiple myeloma
    A M Sherrod
    P Hari
    C A Mosse
    R C Walker
    R F Cornell
    Bone Marrow Transplantation, 2016, 51 : 2 - 12
  • [32] Minimal residual disease testing after stem cell transplantation for multiple myeloma
    Sherrod, A. M.
    Hari, P.
    Mosse, C. A.
    Walker, R. C.
    Cornell, R. F.
    BONE MARROW TRANSPLANTATION, 2016, 51 (01) : 2 - 12
  • [33] Minimal residual disease after allogeneic and autologous stem cell transplant in myeloma
    Owen, RG
    Bybee, A
    Cooke, F
    Haynes, AP
    Johnson, RG
    Smith, GM
    Child, JA
    Russell, NH
    Morgan, G
    Samson, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 620 - 620
  • [34] Update on a comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease.
    Yuen, AR
    Blume, KG
    Rosenberg, SA
    Hoppe, RT
    Chao, NJ
    Long, GD
    Horning, SJ
    BLOOD, 2001, 98 (11) : 401B - 401B
  • [35] High-dose (HDS) chemotherapy and PBPO autografting in follicular and mantle cell lymphomas: Analysis of minimal residual disease and molecular follow-up
    Corradini, P
    Astolfi, M
    Caracciolo, D
    Bondesan, P
    Cherasco, C
    Pileri, A
    Tarella, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1383 - 1383
  • [36] Peripheral blood progenitor cell autografting following high-dose therapy in 76 patients with multiple myeloma
    Goldschmidt, H
    Haas, R
    Hegenbart, U
    Wallmeier, M
    Wannenmacher, M
    Hunstein, W
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1130 - 1130
  • [37] Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
    Takeshi Yoroidaka
    Kentaro Narita
    Hiroyuki Takamatsu
    Momoko Fujisawa
    Shinji Nakao
    Kosei Matsue
    Scientific Reports, 11
  • [38] Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
    Yoroidaka, Takeshi
    Narita, Kentaro
    Takamatsu, Hiroyuki
    Fujisawa, Momoko
    Nakao, Shinji
    Matsue, Kosei
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [39] Minimal Residual Disease-Adapted Therapy in Multiple Myeloma: Current Evidence and Opinions
    Meseha, Mina
    Hoffman, James
    Kazandjian, Dickran
    Landgren, Ola
    Diamond, Benjamin
    CURRENT ONCOLOGY REPORTS, 2024, 26 (06) : 679 - 690
  • [40] Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma
    Foureau, David
    Bhutani, Manisha
    Guo, Fei
    Rigby, Katherine
    Leonidas, Marina
    Tjaden, Elise
    Fox, Andee
    Atrash, Shebli
    Paul, Barry
    Voorhees, Peter M.
    Usmani, Saad Z.
    CANCER MEDICINE, 2021, 10 (20): : 6933 - 6936
12345